Major Depressive Disorder (MDD) Treatment Market

fmiresearch

Major Depressive Disorder (MDD) is one of the most common mental disorder characterized by persistent and tenacious low mood that interferes with the person’s ability to work, eat, sleep and normal activities. MDD is also referred as clinical depression, major depression, and unipolar depression or as recurrent depression. The common symptoms associated with this disorder include insomnia, loss of interest, recurrent thoughts of death, feelings of worthlessness and reduced ability to think. Increasing number of patients suffering from MDD has grabbed the attention of MDD drugs manufacturer to invest into MDD treatment market.

Major Depressive

Disorder (MDD)

Treatment Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2016

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Major Depressive Disorder (MDD) is one of the most common mental disorder

characterized by persistent and tenacious low mood that interferes with the person’s

ability to work, eat, sleep and normal activities. MDD is also referred as clinical

depression, major depression, and unipolar depression or as recurrent depression. The

common symptoms associated with this disorder include insomnia, loss of interest,

recurrent thoughts of death, feelings of worthlessness and reduced ability to think.

Increasing number of patients suffering from MDD has grabbed the attention of MDD

drugs manufacturer to invest into MDD treatment market.

Major Depressive Disorder (MDD) Treatment Market: Drivers and Restraints

Work life imbalances due to change in life style, and increase in MDD patient pool are the

key drivers expected to drive the MDD treatment market over the forecasted period.

Partnerships for co-development and co-marketing of MDD drugs among the drug

manufactures across the globe, development of new drugs, and adequate government

reimbursement policies have also fueled the growth of MDD treatment market. However,

stringent regulations imposed by various governments for new drug approval, patent

expiries of some blockbuster drugs, risk of complications with other edications, elated

side effects of MDD drugs may hinder the growth of MDD treatment market over the

forecasted period.

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1314


Report Description

Major Depressive Disorder (MDD) Treatment Market: Segmentation

The global MDD treatment market is segmented based on drug type used for the

treatment of MDD.

•Antidepressants

• Selective Serotonin Reuptake Inhibitors (Ssris)

• Dopamine Norepinephrine Reuptake Inhibitor

• Serotonin Norepinephrine Reuptake Inhibitor

• Serotonin Modulators

• Norepinephrine-Serotonin Modulator

• Tricyclics and Tetracyclics

• Monoamine Oxidase Inhibitors (MAOIs)

• Irreversible, non-selective inhibitors

• Phenelzine

• Tranylcypromine

• Isocarboxazid

• Irreversible, MAO B selective inhibitor

• Selegiline transdermal

• Reversible, MAO A selective inhibitor


Report Description

•Atypical antidepressants

•Antipsychotics

• Moclobemide

Major Depressive Disorder (MDD) Treatment Market: Overview

At present, antidepressants are most commonly used drugs for the treatment of MDD,

and has the largest market segment. Major brands of SSRI’s include Citalopram,

Escitalopram, Fluoxetine, Paroxetine, and Sertraline. Bupropion, Mirtazapine, and

Razodone, are atypical antidepressants frequently used for the treatment of MDD. Major

brands of antipsychotics includes Resperidone, Olanzapine, Quetiapine, Ziprasidone, and

Aripiprazole. Global MDD treatment market is expected to grow with a healthy CAGR

owing to increase in MDD patient pool over the forecast period.

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1314

Major Depressive Disorder (MDD) Treatment Market: Region-wise Outlook

Geographically, North America market is estimated to hold maximum market revenue

share in global MDD treatment market owing to increase in number of patients suffering

from MDD, and advancement in technology to develop new therapeutic drugs and

followed by Europe and Asia-Pacific respectivily. The market in Asia-Pacific is expected to

expand at a significant CAGR over the forecasted period due to increasing awareness for

depression conditions and complications associated with it.


Report Description

MDD treatment market is expected to register healthier CAGR in emerging markets such

as India, China, and Brazil compared to other developed regions in the world.

Major Depressive Disorder (MDD) Treatment Market: Key Players

Key companies operational in MDD treatment market are Eli Lilly and Company, Johnson

& Johnson, Pfizer, Inc., AstraZeneca plc, Merck & Co., GlaxoSmithKline plc, Sanofi S.A.,

Shire plc, Novartis AG, Janssen Pharmaceutical, Inc., and others.

Browse full report: http://www.futuremarketinsights.com/reports/major-depressivedisorder-treatment-market


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines